001     633005
005     20250723110123.0
024 7 _ |a 10.1038/s41467-025-61145-x
|2 doi
024 7 _ |a 10.3204/PUBDB-2025-02331
|2 datacite_doi
024 7 _ |a altmetric:178622875
|2 altmetric
024 7 _ |a pmid:40595645
|2 pmid
024 7 _ |a openalex:W4411882024
|2 openalex
037 _ _ |a PUBDB-2025-02331
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Myllykoski, Matti
|0 P:(DE-H253)PIP1026906
|b 0
|e Corresponding author
245 _ _ |a The molecular basis for acetylhistidine synthesis by HisAT/NAT16
260 _ _ |a [London]
|c 2025
|b Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1752225242_2516337
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Acetylhistidine has been detected in human blood, but its origin and function are not known. It is formed when the acetyl group of acetyl-CoA is transferred to the α-amino group of histidine. Here we identify the intracellular NAT16 as the human histidine acetyltransferase (HisAT) responsible for histidine acetylation in vitro and in vivo. A NAT16 variant (p.Phe63Ser) present in over 5% of the population was previously found to correlate with reduced plasma levels of acetylhistidine and increased risk of kidney disease. Our biochemical analysis of HisAT/NAT16 Phe63Ser shows reduced affinity for Histidine supporting a model where this variant has less acetylhistidine catalysis leading to lower blood level of acetylhistidine. We find that HisAT adopts a double-GNAT (Gcn5-related N-Acetyltransferase) fold where the N-terminal domain binds acetyl-CoA and with distinct active site conformation allowing the binding of histidine in between the two domains. We detect similar structures from across living organisms and find that the HisAT structure is conserved in several archaeal and bacterial species. In sum, NAT16 is the human histidine acetyltransferase utilizing a rare double-GNAT structure to steer plasma acetylhistidine levels with potential impact for kidney function.
536 _ _ |a 6G3 - PETRA III (DESY) (POF4-6G3)
|0 G:(DE-HGF)POF4-6G3
|c POF4-6G3
|f POF IV
|x 0
536 _ _ |a NterAct - Discovery and functional significance of post-translational N-terminal acetylation (772039)
|0 G:(EU-Grant)772039
|c 772039
|f ERC-2017-COG
|x 1
536 _ _ |a Q-Room - Q-Room – Quintetto’s Holographic Telepresence Room (673617)
|0 G:(EU-Grant)673617
|c 673617
|f H2020-SMEINST-1-2014
|x 2
536 _ _ |a FS-Proposal: BAG-20190768 EC (BAG-20190768-EC)
|0 G:(DE-H253)BAG-20190768-EC
|c BAG-20190768-EC
|x 3
536 _ _ |a FS-Proposal: BAG-20211049 EC (BAG-20211049-EC)
|0 G:(DE-H253)BAG-20211049-EC
|c BAG-20211049-EC
|x 4
588 _ _ |a Dataset connected to CrossRef, Journals: bib-pubdb1.desy.de
693 _ _ |a PETRA III
|f PETRA Beamline P11
|1 EXP:(DE-H253)PETRAIII-20150101
|0 EXP:(DE-H253)P-P11-20150101
|6 EXP:(DE-H253)P-P11-20150101
|x 0
693 _ _ |a PETRA III
|f PETRA Beamline P14
|1 EXP:(DE-H253)PETRAIII-20150101
|0 EXP:(DE-H253)P-P14-20150101
|6 EXP:(DE-H253)P-P14-20150101
|x 1
700 1 _ |a Lundekvam, Malin
|0 0009-0000-9850-8686
|b 1
700 1 _ |a Osberg, Camilla
|0 0000-0003-0249-0536
|b 2
700 1 _ |a Nilsen, Solveig Siqveland
|b 3
700 1 _ |a Arnesen, Thomas
|0 P:(DE-H253)PIP1089770
|b 4
|e Corresponding author
773 _ _ |a 10.1038/s41467-025-61145-x
|g Vol. 16, no. 1, p. 5960
|0 PERI:(DE-600)2553671-0
|n 1
|p 5960
|t Nature Communications
|v 16
|y 2025
|x 2041-1723
856 4 _ |u https://www.nature.com/articles/s41467-025-61145-x#article-info
856 4 _ |u https://bib-pubdb1.desy.de/record/633005/files/The%20molecular%20basis%20for%20acetylhistidine%20synthesis%20by%20HisAT%20NAT16.pdf
|y OpenAccess
856 4 _ |u https://bib-pubdb1.desy.de/record/633005/files/The%20molecular%20basis%20for%20acetylhistidine%20synthesis%20by%20HisAT%20NAT16.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:bib-pubdb1.desy.de:633005
|p openaire
|p open_access
|p driver
|p VDB
|p ec_fundedresources
|p dnbdelivery
910 1 _ |a European Molecular Biology Laboratory
|0 I:(DE-588b)235011-7
|k EMBL
|b 0
|6 P:(DE-H253)PIP1026906
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 0
|6 P:(DE-H253)PIP1026906
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 4
|6 P:(DE-H253)PIP1089770
913 1 _ |a DE-HGF
|b Forschungsbereich Materie
|l Großgeräte: Materie
|1 G:(DE-HGF)POF4-6G0
|0 G:(DE-HGF)POF4-6G3
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-600
|4 G:(DE-HGF)POF
|v PETRA III (DESY)
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-02
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2025-01-02
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT COMMUN : 2022
|d 2025-01-02
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2022
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-01-30T07:48:07Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-01-30T07:48:07Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-02
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2024-01-30T07:48:07Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
920 1 _ |0 I:(DE-H253)EMBL-User-20120814
|k EMBL-User
|l EMBL-User
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-H253)EMBL-User-20120814
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21